116 results
DEFA14A
APVO
Aptevo Therapeutics Inc
23 Apr 24
Additional proxy soliciting materials
4:10pm
Materials
Soliciting Material Pursuant to § 240.14a-12
Aptevo Therapeutics Inc.
(Name of Registrant as Specified In Its Charter)
(Name of Person(s) Filing … with preliminary materials.
Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11.
APTEVO THERAPEUTICS INC. C/O
8-K
EX-10.2
APVO
Aptevo Therapeutics Inc
15 Apr 24
Aptevo Therapeutics Announces Pricing of $4.6 Million Public Offering
4:17pm
hereof (or such shorter period as the Company was required by law or regulation to file such material) (the foregoing materials, including … , releases or threatened releases of chemicals, pollutants, contaminants, or toxic or hazardous substances or wastes (collectively, “Hazardous Materials
8-K
EX-10.1
APVO
Aptevo Therapeutics Inc
15 Apr 24
Aptevo Therapeutics Announces Pricing of $4.6 Million Public Offering
4:17pm
or filed as required.
(c)Offering Materials. Neither the Company nor any of its directors and officers has distributed and none of them … or services referred to above or (y) use of any offering materials or information concerning the Company in connection with the offer or sale
DEFR14A
4rcwbueb7ca9md1fffc
30 Jan 24
Revised proxy
8:00am
DEFR14A
6qhr 2qeka5vrf
16 Jan 24
Revised proxy
4:15pm
8-K
EX-10.1
w5oj99usd4w4ytx59w4
9 Nov 23
Entry into a Material Definitive Agreement
5:17pm
8-K
EX-10.2
utko57ks
4 Aug 23
Entry into a Material Definitive Agreement
6:51pm
8-K
EX-10.1
s120k
4 Aug 23
Entry into a Material Definitive Agreement
6:51pm